Citation Impact
Citing Papers
Advances in Laboratory Methods for Detection and Typing of Norovirus
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy
2013 Standout
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
2020 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
2008 Standout
Staphylococcal adhesion to collagen in intpa-articular sepsis
1988
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
Diagnosis and Epidemiology of Cirrhosis
2009
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
Liver fibrosis
2005 Standout
Direct Identification of Bacteria in Positive Blood Culture Bottles by Matrix-Assisted Laser Desorption Ionisation Time-of-Flight Mass Spectrometry
2009
Cystic fibrosis
2016 Standout
Management of patients with chronic hepatitis C infection
2006
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
2004
Biochemical Surrogate Markers of Liver Fibrosis and Activity in A Randomized Trial of Peginterferon Alfa–2B and Ribavirin
2003
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Screening in liver disease: Report of an AASLD clinical workshop
2004
Osteomyelitis
1997 Standout
FibroTest-FibroSURE™: towards a universal biomarker of liver fibrosis?
2005
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
2011 Standout
Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies
2006
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
2004
COVID-19: A promising cure for the global panic
2020 Standout
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients
2004
Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram‐Positive Bacterial Infections
2004
Psoriasis
2021 Standout
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C
2006
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis – a review
2009
Chapter 4 Biomarkers Of Liver Fibrosis
2008
The NAFLD fibrosis score
2007 Standout
Non-alcoholic fatty liver disease
2021 Standout
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
2008
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
2019
In vivo ribavirin activity against severe pandemic H1N1 influenza A/Mexico/4108/2009
2010
Lessons Learned from Animal Models of Osteomyelitis
1988
Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance
2013
Hepatitis C virus: How genetic variability affects pathobiology of disease
2011
Noninvasive assessment of liver fibrosis
2010
An automated genotyping tool for enteroviruses and noroviruses
2011
FIB-4
2007 Standout
Calculating the sample size required for developing a clinical prediction model
2020 Standout
Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion
2020
Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study
2011
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)
2010
Nonalcoholic fatty liver disease
2005 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Serum markers detect the presence of liver fibrosis: A cohort study
2004
Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
2013 Standout
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Noninvasive Measures of Liver Fibrosis
2006
Infections in Patients with Cystic Fibrosis
2014
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
2007 Standout
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
2020 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Do We Still Need a Liver Biopsy? Are the Serum Fibrosis Tests Ready for Prime Time?
2006
Management of Crohn's Disease in Adults
2009 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography
2008
Rapid genotyping of Achromobacter xylosoxidans, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolates using melting curve analysis of RAPD-generated DNA fragments (McRAPD)
2011
SARS-CoV-2 in wastewater: State of the knowledge and research needs
2020 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Evaluation of Liver Fibrosis: A Concise Review
2004
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis
2018
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
2018
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
Prediction of Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Infection by Serum Proteomic Fingerprinting: A Pilot Study
2005
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013
2016
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis
2014
Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
2019
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests
2005
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Monitoring human enteric viruses in wastewater and relevance to infections encountered in the clinical setting: a one-year experiment in central France, 2014 to 2015
2018
Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysis
2014
Genotyping Study of Scedosporium apiospermum Isolates from Patients with Cystic Fibrosis
2002
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
2013
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C
2004
Works of David Speers being referenced
Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?
2004
Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection
2010
Comparison of noninvasive models of fibrosis in chronic hepatitis B
2011
Emergence of multi-resistant Pseudomonas aeruginosa in a Western Australian hospital
2010
Meningitis and a Febrile Vomiting illness Caused by Echovirus Type 4, Northern Territory, Australia
2009
Enterovirus D68 disease and molecular epidemiology in Australia
2015
Ultrastructural studies of adherence of Staphylococcus aureus in experimental acute hematogenous osteomyelitis
1985
Evaluation of Four Methods for Rapid Identification of Staphylococcus aureus from Blood Cultures
1998
Evaluation of the Cepheid Xpert Flu Assay for Rapid Identification and Differentiation of Influenza A, Influenza A 2009 H1N1, and Influenza B Viruses
2012
Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection
2005
Molecular Epidemiology of Scedosporium apiospermum Infection Determined by PCR Amplification of Ribosomal Intergenic Spacer Sequences in Patients with Chronic Lung Disease
2001
Oseltamivir‐resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case
2010
Validation of the FibroTest Biochemical Markers Score in Assessing Liver Fibrosis in Hepatitis C Patients
2003
Real-Time PCR Assay for Detection of blaZ Genes in Staphylococcus aureus Clinical Isolates
2014